- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06866886
EEG-Guided Sedation in ERCP Procedures (ERCP-EEG)
Evaluation of the Depth of Sedation in Patients Undergoing Endoscopic Retrograde Cholangio Pancreatography (ERCP) With 4-Channel Electroencephalography (EEG)
Patients undergoing ERCP have a wide range from patients with poor general condition and septicaemia findings to outpatients who come as day patients without any other additional disease. Rapid deterioration in vital signs may be encountered especially during sedation. In this patient group, it is important to titrate the anaesthetic agent at appropriate doses and to adjust the dose according to the patient.
The aim of the study is to optimise the level of sedation using 4-channel electroencephalography (EEG) in these patients, thus providing balanced anaesthesia and rapid recovery in this already challenging patient group.
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Ankara Bilkent City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- ASA I-II-III risk score
- Volunteer patients
- Patients aged 18-65 years of both sexes undergoing elective ERCP procedure
Exclusion Criteria:
- Patient reluctance
- Being under 18 years of age
- Being over 65 years of age
- ASA risk score of 4 and above 4
- Pregnant women
- Those with neurological conditions
- Patients with difficult airways
- Obesity (BMI>30)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
CASE GROUP
All patients will undergo routine monitoring, including ECG, blood pressure, SpO₂, respiratory rate, and end-tidal CO₂ measurements.
42 patients receiving EEG-based Patient State Index (PSI) monitoring to optimize sedation depth.
PSI electrodes will be applied, and sedation levels will be adjusted accordingly.
Oxygen will be administered at 2 L/min via a nasal cannula.
Propofol will be used for sedation, with doses adjusted based on patient needs.
Any complications that arise and the interventions performed will also be recorded.
The procedure duration, total anesthesia duration, total anesthetic dosage, time to awakening from anesthesia (Ramsey Score: 1), and full recovery time (Aldrete Score: 10) will be recorded.
|
|
CONTROL GROUP
All patients will undergo routine monitoring, including ECG, blood pressure, SpO₂, respiratory rate, and end-tidal CO₂ measurements.
42 patients receiving standard clinical sedation monitoring without EEG guidance.
Sedation levels will be assessed using the Ramsey Sedation Scale (RSS).
Propofol will be used for sedation, with doses adjusted based on patient needs.
Oxygen will be administered at 2 L/min via a nasal cannula.
Additionally, sedation levels will be evaluated every five minutes using the Ramsey Sedation Scale (RSS).
An RSS score of 2-3 will be classified as light sedation, while a score of 4 will indicate deep sedation.
Any complications that arise and the interventions performed will also be recorded.
The procedure duration, total anesthesia duration, total anesthetic dosage, time to awakening from anesthesia (Ramsey Score: 1), and full recovery time (Aldrete Score: 10) will be recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Anesthetic Consumption
Time Frame: From anesthesia induction to the end of sedation during the ERCP procedure
|
The total amount of propofol (mg/kg) administered during the ERCP procedure
|
From anesthesia induction to the end of sedation during the ERCP procedure
|
|
Recovery Time from Anesthesia
Time Frame: Assessed at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes post-anesthesia discontinuation, up to 60 minutes.
|
The time required for the patient to regain consciousness after anesthesia, defined as the time to reach Aldrete Score of 10
|
Assessed at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes post-anesthesia discontinuation, up to 60 minutes.
|
|
Sedation Depth Maintenance
Time Frame: Sedation depth will be continuously monitored during the procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes (PSI Score).
|
The ability to maintain an optimal sedation level, defined as a Patient State Index (PSI) value around 50, throughout the ERCP procedure. Measurement Scale: Scale Used: Patient State Index (PSI) - Masimo SedLine Brain Function Monitor Score Range: 0 to 100 Interpretation: 0-12: Burst suppression (deep anesthesia) 25-50: Optimal sedation for general anesthesia >50: Light sedation or wakefulness Higher scores indicate lighter sedation, while lower scores indicate deeper sedation. |
Sedation depth will be continuously monitored during the procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes (PSI Score).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemodynamic Stability
Time Frame: Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
Non-Invasive Arterial Blood Pressure (mmHg), including systolic, diastolic, and mean arterial pressure, measured using an automated non-invasive blood pressure monitor to compare intraoperative hemodynamic stability between the EEG-guided sedation group and the standard sedation group.
|
Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
|
Hemodynamic Stability
Time Frame: Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
Heart Rate (beats per minute), measured using standard ECG monitoring to compare intraoperative heart rate stability between the EEG-guided sedation group and the standard sedation group.
|
Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
|
Hemodynamic Stability
Time Frame: Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
Oxygen Saturation (SpO₂, %) measured using pulse oximetry to assess intraoperative oxygenation levels in patients undergoing EEG-guided sedation versus standard sedation during the ERCP procedure.
|
Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
|
Hemodynamic Stability
Time Frame: Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
Respiratory Rate (breaths per minute) measured using continuous respiratory monitoring to assess intraoperative respiratory stability in patients undergoing EEG-guided sedation versus standard sedation during the ERCP procedure.
|
Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
|
Hemodynamic Stability
Time Frame: Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
End-Tidal CO₂ (mmHg) measured using capnography to assess intraoperative ventilation status and respiratory function in patients undergoing EEG-guided sedation versus standard sedation during the ERCP procedure.
|
Continuously monitored during the ERCP procedure and recorded at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, and 55 minutes.
|
|
Incidence of Respiratory and Cardiovascular Complications
Time Frame: During the ERCP procedure (intraoperative period)
|
The frequency of complications such as hypoxia, apnea, bradycardia, and hypotension
|
During the ERCP procedure (intraoperative period)
|
|
Intervention Rate Due to Sedation-Related Instability
Time Frame: During the ERCP procedure (intraoperative period)
|
The need for additional interventions such as airway support, fluid therapy, vasopressors, or increased oxygen administration due to sedation-related complications
|
During the ERCP procedure (intraoperative period)
|
|
Time to Awakening from Anesthesia
Time Frame: Assessed at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes post-anesthesia discontinuation, up to 60 minutes.
|
The time taken for the patient to regain consciousness, defined as the time to reach Ramsey Sedation Score (RSS) of 1. Scale Used: Ramsey Sedation Scale (RSS) Score Range: 1 to 6 Interpretation: 1: Patient is awake, anxious, and agitated 2-3: Light sedation (responsive to verbal commands) 4: Deep sedation (responsive to light stimuli) 5-6: Unresponsive to stimuli (very deep sedation) Higher scores indicate deeper sedation, while lower scores indicate increased wakefulness. |
Assessed at 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes post-anesthesia discontinuation, up to 60 minutes.
|
|
Total Procedure Duration
Time Frame: From the start to the completion of the ERCP procedure
|
The overall time taken to complete the ERCP procedure
|
From the start to the completion of the ERCP procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ayça Özcan, Ankara City Hospital Bilkent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EthicsApproval: E2-24-7125
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.